Reveles Clinical Services Founder and CEO Elected to Serve on Association of Clinical Research Professionals Board of Trustees
Dallas, TX January 11, 2022 – Founder and CEO of Reveles Clinical Services, R’Kes Starling, RPh, MBA, was elected to serve on the Association of Clinical Research Professionals (ACRP) Board of Trustees, furthering the organization’s goal of expanding access and diversity in clinical trials.
Starling began as a founding member of ACRP’s Diversity Advisory Council (DAC) in its inaugural year and still serves as chairperson. Through his tenure, he has utilized his expertise in the field to further ACRP’s goals, including expanding diversity in the clinical research workforce, enriching existing minority staff, and educating the scientific community on the importance of diversity in the workplace.
“It is an honor to join such an esteemed group of peers as a member of the Board. I am so proud of the milestones ACRP’s Diversity Advisory Council has accomplished and look forward creating and implementing more strategic solutions for critical clinical trials through this new role,” Starling said. “Reveles Clinical Services was established to provide greater access to cutting-edge treatments, which directly aligns with ACRP’s work. I am humbled by the impact both organizations are making within the field of clinical research and diversity, equity, and inclusion.”
Starling will serve a two-year term starting January 2022. More information on ACRP and its mission can be found here.
About Reveles Clinical Services
Reveles Clinical Services brings next generation, comprehensive clinical trial services to drug developers and therapy innovation, with an emphasis on underserved patients in need of critical care for rare and complex diseases. Through a decentralized continuum, Reveles is commitment to addressing the underrepresentation in clinical research, both through patient care and within the workforce, by increasing awareness and expanding access to groundbreaking research. Reveles strives to optimize the lengthy and expensive clinical trial process by leveraging advanced technology and in-home clinical trial services, bringing hope closer to home. For more information visit.
Media Contact:
Liane Smith
214-862-0779
Comments